SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Lupus
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (8)
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by La Cava, A
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by La Cava, A
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

review-article

T-regulatory cells in systemic lupus erythematosus

A La Cava

Division of Rheumatology, Department of Medicine, University of California Los Angeles, Los Angeles, California, USA

Thymus-derived CD4+CD25highFoxp3+ T-regulatory cells (Tregs) have an important role in the mechanisms of peripheral immune tolerance and in the prevention of pathogenic autoimmunity through the suppression of proliferation and production of pro-inflammatory cytokines in effector immune cells. Some studies have shown that in systemic lupus erythematosus (SLE) the number of circulating Tregs may be decreased during active disease, and that the extent of such decrease may correlate with severity of the disease. Recent data in murine models of lupus have suggested the possibility to target Tregs for the modulation of SLE, and Treg-based intervention has been proposed as a novel therapeutic mean for a better management of the disease. This review provides an update on the role of Tregs in SLE, discussing new findings in relation to possible targeting of Tregs for immune modulation in lupus.

Lupus, Vol. 17, No. 5, 421-425 (2008)
DOI: 10.1177/0961203308090028
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 J. Immunol.Home page
E. V. Lourenco, C. Procaccini, F. Ferrera, N. Iikuni, R. P. Singh, G. Filaci, G. Matarese, F.-D. Shi, E. Brahn, B. H. Hahn, et al.
Modulation of p38 MAPK Activity in Regulatory T Cells after Tolerance with Anti-DNA Ig Peptide in (NZB x NZW)F1 Lupus Mice
J. Immunol., June 15, 2009; 182(12): 7415 - 7421.
[Abstract] [Full Text] [PDF]

Home page
 Stem CellsHome page
L. Sun, K. Akiyama, H. Zhang, T. Yamaza, Y. Hou, S. Zhao, T. Xu, A. Le, and S. Shi
Mesenchymal Stem Cell Transplantation Reverses Multiorgan Dysfunction in Systemic Lupus Erythematosus Mice and Humans
Stem Cells, June 1, 2009; 27(6): 1421 - 1432.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
D. Q. Tran, J. Andersson, D. Hardwick, L. Bebris, G. G. Illei, and E. M. Shevach
Selective expression of latency-associated peptide (LAP) and IL-1 receptor type I/II (CD121a/CD121b) on activated human FOXP3+ regulatory T cells allows for their purification from expansion cultures
Blood, May 21, 2009; 113(21): 5125 - 5133.
[Abstract] [Full Text] [PDF]

Home page
 LupusHome page
A La Cava
Lupus and T Cells
Lupus, March 1, 2009; 18(3): 196 - 201.
[Abstract] [PDF]


Advertisement